Soluble glycosaminoglycans do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1

Virology

Volumn 278, Issue 2, 2000, Pages 412-422

  Ylisastigui, Loyda ^a   Bakri, Youssef ^a,b   Amzazi, Saäd ^a,b   Gluckman, Jean Claude ^a   Benjouad, Abdelaziz ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b FACULTÉ DES SCIENCES   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHONDROITIN 4 SULFATE; COLONY STIMULATING FACTOR 1; CYTOKINE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN MDM5D; RANTES; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MACROPHAGE; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034531983     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0670     Document Type: Article

References (71)

1. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophagetropic HIV-1
2. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor downmodulation
3. HIV coreceptor downregulation as antiviral principle. SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HW replication
4. The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type 1 depends on the macrophage activation state
5. HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages
6. A new classification for HIV-1
7. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
8. Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling
9. The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage
10. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
11. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
12. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
13. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
14. Requirement of MIP-1 alpha for an inflammatory response to viral infection
15. Identification of a major co-receptor for primary isolates of HIV-1
16. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages
17. Modulation of cAMP-dependent protein kinase by derivatives of chondroitin sulfate
18. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
19. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
20. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
21. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
22. Binding of recombinant HIV coat protein gp120 to human monocytes
23. The role of mononuclear phagocytes in HTLV-II/LAV infection
24. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
25. Glycosaminoglycans mediate cell surface oligomerization of chemokines
26. Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes, and are infectious for T lymphocytes
27. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines
28. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses
29. Identification of a glycosaminoglycan binding surface on human interleukin-8
30. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5
31. Glycosaminoglycans and their binding to biological macromolecules
32. HIV-1 gp120, and chemokines activate ion channels in primary macrophages through CCR5, and CXCR4 stimulation
33. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
34. Differential loss of envelope glycoprotein glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: Effects on infectivity and neutralisation
35. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection
36. CD8+ T-cell-derived soluble factor(s), but not betachemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages
37. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
38. Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection
39. CD4-negative cells bind human immunodeficiency virus type 1, and efficiently transfer virus to T cells
40. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans
41. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines
42. Human immunodeficiency virus (HIV) infection of the uterine cervix
43. Chemokine receptors: Gateways to inflammation and infection
44. The chemokine family: Potential therapeutic targets from allergy to HIV infection
45. Signalling heterogeneity as a contributing factor in macrophage functional diversity
46. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120gp41
47. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes
48. Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils
49. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
50. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level
51. Chemokines and HIV replication
52. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
53. Receptor-mediated endocytosis of CC-chemokines
54. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression
55. 1H-NMR studies of bovine platelet factor 4: Histidine assignments and interactions with heparin
56. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta
57. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity
58. Modulation of the expression of chondroitin sulfate proteoglycan in stimulated human monocytes
59. Proteoglycan metabolism in normal and inflammatory human macrophages
60. Characteristics of human mononuclear phagocytes
61. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells
62. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
63. Betachemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
64. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8
65. Differential binding of chemokines to glycosaminoglycan subpopulations
66. Modulation of macrophage and B cell function by glycosaminoglycans
67. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
68. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1
69. Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2
70. Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages
71. Genotypic and phenotypic characterization of HIV-1 patients with primary infection